Treatment for patients undergoing breast reconstruction is often complex, requiring special expertise from multiple providers. This study surveyed medical oncologists and plastic surgeons about their knowledge, attitudes, and communication related to treatment of patients undergoing breast reconstruction. Identifying the gaps in understanding of treatment course, understanding each provider's responsibility in timely care, and increasing communication about a patient's treatment could improve patient care and enhance safety of breast reconstruction. Objectives: Communication between medical oncologists (MOs) and plastic surgeons (PSs) is important to optimize outcomes for patients with breast cancer seeking breast reconstruction. We sought to evaluate the knowledge MOs and PSs have of each others' fields, roles expected of each other, and frequency of communication. Methods: A cross-sectional survey was conducted in a convenience sample of MOs and PSs. The survey included knowledge questions about reconstruction and chemotherapy, questions about provider and patient responsibilities for timely chemotherapy initiation, and questions about communication with other specialties. Results: MOs and PSs had similar knowledge scores (MOs, 59%; PSs, 56%; P ¼ .5), but both lacked knowledge about aspects of the other specialty's field related to breast reconstruction. The MOs and PSs agreed on the MOs' degree of responsibility for timely chemotherapy initiation (MOs mean, 4.6; PSs mean, 4.4 (out of 5); P ¼ .2). However, they disagreed about the PS's responsibility for timely chemotherapy initiation (MOs mean, 3.8; PSs mean, 3.0; P ¼ .01). Communication occurred about 2.5 times more often for patients with complications than patients without complications (P < .0001). Conclusion: MOs and PSs have deficits in knowledge about each other fields and differ in their opinion regarding the burden of responsibility in ensuring timely chemotherapy initiation, suggesting room for improvement in communication and understanding.
fields. For example, PSs generally receive minimal education about systemic therapy. Thus, they may not know which reconstruction patients are most likely to need adjuvant chemotherapy, or how reconstructive complications affect the timeliness of chemotherapy initiation. MOs generally do not receive formal education about reconstructive procedures, so they may not know how problems with healing are managed. MOs and PSs are unlikely to encounter each other during their normal workday. Further, some clinical settings may lack a multidisciplinary conference where interaction among breast providers could occur. Not having direct interaction may result in poorer communication and less appropriate care. 15 High levels of communication and coordination, by contrast, are associated with more appropriate, guideline-concordant care. 16, 17 We sought to evaluate the quality of MOs' and PSs' knowledge and communication about patients with breast cancer undergoing immediate breast reconstruction and adjuvant chemotherapy. Our specific objectives were three-fold: (1) to evaluate the knowledge MOs and PSs have of each other's fields, relevant to breast cancer therapy/reconstruction; (2) to describe the attitudes MOs and PSs have towards treatment of patients with breast cancer, including responsibilities and roles in ensuring optimal care; and (3) to evaluate the self-reported practices of MOs and PSs in the postoperative care of women undergoing breast reconstruction and adjuvant chemotherapy.
Methods

Study Design
The study was approved by the University of North Carolina Institutional Review Board (#10-0511). A cross-sectional survey was conducted in a convenience sample of MOs and PSs. Surveys were distributed by mail and email, and at 2 regional professional meetings (medical oncology and plastic surgery) in the Southeast region of the United States. We included only PSs who reported performing at least 1 breast reconstruction per year and MOs who reported treating at least 5 patients with breast cancer per year.
Measures
The survey consisted of questions about demographics and practice characteristics, and questions in the following 3 domains: (1) knowledge about immediate breast reconstruction and chemotherapy; (2) attitudes about who is most responsible for timely chemotherapy initiation; and (3) practice behaviors related to communication or coordination with other specialties. To develop these questions, we considered which aspects of breast reconstruction affect medical oncology practice, and which aspects of chemotherapy administration affect plastic surgery practice. The surveys for the 2 specialties were identical, except for some wording variation to make the question more appropriate to the respective specialty. We pilot-tested an initial draft of the surveys in convenience samples of 4 PSs and 3 MOs and revised them based on their feedback. The survey is available in Appendix I in the online version.
Knowledge Questions About Immediate Breast Reconstruction. The general knowledge questions ask about the frequency of complications after immediate breast reconstruction 9 and the frequency of clinically significant chemotherapy delays owing to reconstruction. Case descriptions evaluate knowledge about when to start chemotherapy in a patient with a complication and knowledge about the management of reconstruction complications (open wound, seroma).
Knowledge Questions About Systemic Therapy. Four case descriptions evaluate knowledge about systemic therapy. We were specifically interested in knowledge about (1) indications for chemotherapy, because this could affect healing; (2) indications for endocrine therapy, because this could affect venous thromboembolism or microvascular thrombosis risks; (3) timing of trastuzumab (herceptin), because it is given every 3 weeks for a year during which additional stages of reconstruction occur; and (4) treatment after neoadjuvant chemotherapy in high-risk patients, because those patients need to have rapid healing after reconstruction in order to proceed to adjuvant radiation therapy on time.
Attitude Questions. We asked participants to rate the responsibility of MOs, surgical oncologists, PSs, and the patient in ensuring timely initiation of chemotherapy. We asked MOs to rate the importance of immediate breast reconstruction when planning adjuvant chemotherapy, and we asked PSs to rate the importance of the likelihood of chemotherapy when planning immediate breast reconstruction. We asked how necessary it was for the MO and PS to communicate about a patient undergoing reconstruction scheduled to have chemotherapy.
Practice Behavior Questions. To evaluate practice behaviors related to communication or coordination of care, we asked MOs how often they knew what type of breast reconstruction a patient who had undergone chemotherapy had received, and PSs how often they knew the likelihood of chemotherapy for a patient undergoing reconstruction before surgery. We asked each specialty how often they would communicate with the other specialty about a patient undergoing breast reconstruction who needed chemotherapy, for both those who were and were not having wound healing complications.
Statistical Considerations
The knowledge measures showed general construct validity, with PSs scoring higher than MOs on the questions about surgical healing, and MOs scoring higher than PSs on the questions about systemic therapy. Formal validity testing, however, was not performed. One question about infection after breast reconstruction was discarded because a high percentage of PSs (35%) answered incorrectly.
Descriptive statistics were computed, and the Wilcoxon Rank Sum test for continuous variables and the Fisher exact test for categorical variables were used for comparisons between groups. For the 8 knowledge questions, missing responses and "I don't know" were considered incorrect. The frequency of answering a question correctly was compared between specialties and compared between groups using the Fisher exact test. A total knowledge score was computed by dividing the number of correct responses by the total number of knowledge questions. Associations between practice characteristics (monthly volume of new patients with breast cancer,
Coordination of Care for Breast Reconstruction Patients practice setting, and attendance at multidisciplinary conferences) and total knowledge score were assessed with the Kruskal-Wallis test. Responses to the attitude and communication items were compared between specialties using the Wilcoxon Rank Sum and Fisher exact tests as appropriate.
Results
Sample Characteristics
The sample consisted of 23 PSs and 53 MOs, with an overall response rate of 51% of those that received the survey in the mail, by email, or at regional professional meetings. Most participants were male (MOs, 60%; PSs, 83%) and had been practicing fewer than 20 years (MOs, 68%; PSs, 70%) ( Table 1 ). Both specialties reported seeing an average of 6 new patients with breast reconstruction per month. Most of the MOs were in academic practice (57%), whereas most of the PSs were in private practice (69%). About 90% of participants in both groups reported that their institution had a multidisciplinary breast conference. Of these, more MOs than PSs regularly attended the conference (100% vs. 70%; P < .0001).
Knowledge
The total knowledge score was slightly higher among MOs (69%) compared with PSs (61%; P ¼ .06). No significant differences were seen based on age, gender, years practicing, practice setting (academic vs. private-urban vs. private-rural), monthly volume of new patients with breast cancer, or attendance at multidisciplinary conference (all P > .08).
General knowledge about breast reconstruction complications and chemotherapy delays was similar between the 2 specialties. Specifically, most MOs (64%) and most PSs (78%; P ¼ .35) answered correctly that breast reconstruction was not associated with chemotherapy delays that affect survival. 8 However, only a minority of MOs (21%) and half of PSs (48%; P ¼ .03) could estimate the approximate complication rate in the first year after immediate breast reconstruction (correct response, 10%-40% [18] [19] [20] ). Most participants selected "less than 10%."
MOs showed uneven knowledge about processes of care after breast reconstruction and before the start of chemotherapy (Table 2) . Specifically, 77% of MOs did not know that the treatment for extensive breast skin necrosis is debridement and skin graft. Most MOs (60%) did know, however, that the correct treatment for a large seroma is aspiration and drainage. Nonetheless, 17% chose "No treatment. Proceed with chemotherapy." Most MOs (79%) knew that tissue expansion is performed concurrently with chemotherapy.
PSs showed uneven knowledge about indications for systemic therapy (Table 2) . Specifically, 86% of PSs did not know that a patient who had received neoadjuvant chemotherapy for a triplenegative tumor did not need further systemic therapy. In fact, 55% responded that the next treatment was chemotherapy. Similarly, 70% of PSs did not know that a patient with a Her2/neupositive tumor would need chemotherapy and trastuzumab (herceptin), followed by trastuzumab for up to 1 year. Most PSs knew the proper systemic treatment for patients with a small, hormone-receptor-positive, lymph-node-negative tumor and for patients with a larger, lymph-node-positive tumor. However, most PSs (65%) did not know that chemotherapy should start 1 week after drain removal, with 26% responding that chemotherapy would start 1 month after drain removal, and 26% responding that chemotherapy would start with drains in place.
Attitudes
We asked participants to rate the MO, surgical oncologist, PS, and patient, in terms of responsibility for ensuring timely start of chemotherapy, on a scale from 1 (not responsible at all) to 5 (completely responsible). MOs and PSs rated the MO's responsibility as high (MOs, 4.61; PSs, 4.43; P ¼ .2) and the SO's responsibility as somewhat high (MOs, 3.66; PSs, 3.74; P ¼ .99). However, MOs rated the PSs' responsibility higher than PSs did (MOs, 3.84; PSs, 3.00; P ¼ .01). MOs also rated the patient's responsibility higher than did PSs (MOs, 3.58; PSs, 2.87; P ¼ .03). Both specialties agreed that MOs and PSs should communicate about a mutual patient who is starting chemotherapy (MOs, 4.1; PSs, 4.1; P ¼ .83).
Practice Behaviors
We asked each specialty how much they considered reconstruction (for MOs) or chemotherapy (for PSs) when planning their For those who had a multidisciplinary clinic available (N ¼ 64).
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Clinical Breast Cancer April 2017 -e61 treatments (0-10 scale, 0 ¼ "not at all," 10 ¼ "a great deal"). MOs did not strongly consider whether a patient had had breast reconstruction when planning chemotherapy (mean score, 2.5; SD, 2.5). Similarly, PSs did not strongly consider the likelihood of adjuvant chemotherapy when planning immediate breast reconstruction (mean score, 3.6; SD, 3.1). MOs reported knowing a patient's type of breast reconstruction 89% of the time, on average, whereas PSs reported knowing the likelihood of chemotherapy for a patient undergoing reconstruction 62% of the time (P < .0001). For a patient without a complication, both specialties reported communicating a few times over 6 months (MOs mean, 1.59; PSs mean, 1.78; P ¼ .18). For a patient with a complication, both specialties reported communicating more frequently (MOs, 4.18; PSs, 3.48; P ¼ .65; comparison of uncomplicated to complicated P < .001).
Discussion
In this sample of MOs and PSs who treat patients with breast cancer, providers from both specialties had substantial knowledge deficits and differed in their attitudes about responsibilities regarding patient care. Both specialties lacked knowledge about basic processes of care specific to the other field, and each group reported infrequent communication with the other specialty, except when a patient had complications.
The underestimation of complication rates after breast reconstruction by both specialties has important implications for patient care and provider training. Not all studies have shown a delay in receipt of adjuvant chemotherapy for patients undergoing immediate breast reconstruction 21 ; however, when surgical complications occur for patients undergoing immediate breast reconstruction, subsequent adjuvant therapy is delayed. 22 Whereas oncologic outcomes for patients both with and without surgical complications may not differ in most cases, coordination of care across specialties could help reduce delays when complications arise providing better continuity of care for the patient. Academic MOs and PSs have an opportunity to educate their trainees about coordination and communication with other specialties but may choose not to if they believe the risk of complications is low. We were somewhat surprised that PSs underestimated breast reconstruction complication rates, because they take care of those complications. This may be an example of optimism bias, in which people tend to overestimate their own qualities or abilities. 23 MOs may have underestimated complication rates because they tend to see patients with breast reconstruction after surgical complications have resolved and have become less memorable. 24 The knowledge deficit that each specialty had about the other specialty has important implications for the timeliness of chemotherapy initiation. If MOs knew appropriate treatment regiments for a large area of skin necrosis, they could actively discuss this with the PSs to facilitate timely chemotherapy initiation. Similarly, most PSs did not know how drains affect chemotherapy initiation. The correct response-waiting 1 week after drain removal-allows the provider to check for seroma formation prior to starting chemotherapy. [25] [26] [27] These misconceptions reflect a lack of understanding by PSs about the importance of timely drain removal that could result in chemotherapy treatment delays. Knowledge deficits about the other specialty also could affect timing for subsequent stages of surgery. More patients than ever are undergoing neoadjuvant chemotherapy and immediate reconstruction prior to radiation. 19, [28] [29] [30] Patients who have all of these treatments must have full range of motion of the arms and complete expansion of a tissue expander or complete healing of a flap prior to radiation, which commonly starts 6 weeks after surgery. Based on current standard of care, such a patient would generally not receive more chemotherapy unless on a clinical trial and would have little time for healing before radiation would need to start. Additionally, knowledge of the trastuzumab administration schedule helps to prevent surgical procedures from interrupting the treatment plan and facilitates continuity of care across specialties. MOs would benefit from knowing that PSs feel less responsible for timely chemotherapy initiation, so that they can proactively involve the PS in making sure a patient is healed in time for chemotherapy. An increase in communication between providers early in treatment planning would help alleviate some of these issues and improve patient care.
The infrequent communication between MOs and PSs seen in this study may be inadequate in cases where the patient is high risk oncologically, surgically, or both. Communication between the MO and other providers may be particularly important, however, because patients hold their oncologists primarily responsible for communication among their breast cancer providers. 31 Such interdisciplinary communication and coordination of care would be more likely to occur in a multidisciplinary breast conference or This study had some limitations. We developed ad hoc measures of knowledge, attitudes, and communication practices. The measures had general acceptability in informal testing with providers from both specialties and showed basic face validity. Nonetheless, actual validity and reliability were not formally tested. In particular, we do not know whether or not the questions that showed very low knowledge levels were too difficult. Whereas we would not expect providers to know everything about the other specialty, we would hope that knowledge would be greater than what we found in this study. We also acknowledge that minor differences in practices may exist, and that some issues are patient-specific, which may explain differing answers on some questions. We also acknowledge that the providers included in this survey may not be representative of all breast care providers. In general, providers in this cohort may see more patients with breast cancer that the average provider. Respondents could have looked up the correct answers to the knowledge questions, although the low level of knowledge for many of the questions suggests otherwise. The measurements of communication and coordination practices were self-reported. We would expect self-reported practices to generally result in inflation of responses in the direction of greater communication and coordination of care.
The provider samples were convenience samples and somewhat homogeneous within each specialty (mostly academic for the MOs, mostly private practice for the PSs), so our findings may not be generalizable to all providers in all practice settings.
Conclusion
MOs and PSs had substantial deficits in knowledge about each others' fields and differed in their opinions about the burden of responsibility in ensuring timely chemotherapy initiation. Although both MOs and PSs increased their communication when complications arose, these results suggest room for improvement in communication and understanding, particularly in patients with an uncomplicated course of care, which could improve the care of patients with breast cancer who undergo immediate breast reconstruction and chemotherapy.
Clinical Practice Points
It has been well-documented that patients with cancer would have more timely care if there was better communication and coordination among providers. Breast cancer treatment is often complex and requires special expertise from multiple types of providers increasing the need for coordinated care. In general, coordination around breast reconstruction and oncologic care has not been addressed. This study found that MOs and PSs had limited knowledge about the treatment course of the other's specialty, which could contribute to delays in care and poorer patient outcomes. They also disagreed about the level of responsibility each had in ensuring timely chemotherapy initiation, and they often failed to communicate regularly about a patient's course of treatment unless complications arose. Identifying these gaps in understanding of treatment course, understanding each provider's responsibility in timely care, and increasing communication about a patient's treatment could improve patient care and enhance safety of breast reconstruction.
